Vivek Ramaswamy

Vivek Ramaswamy
Ramaswamy in 2023
Vivek Ramaswamy
Born	Vivek Ganapathy Ramaswamy 8/9/1985
Birthplace	Cincinnati, Ohio, U.S.
Nationality	American
Occupation	Entrepreneur, politician, author
Known for	Founder of Roivant Sciences; 2024 Republican presidential candidate; Co-head of Department of Government Efficiency
Education	Harvard University (BA) Yale Law School (JD)
Spouse(s)	Apoorva Ramaswamy (m. 2015)
Children	2

Vivek Ganapathy Ramaswamy (born August 9, 1985) is an American entrepreneur, author, and politician who rose to national prominence as the founder of Roivant Sciences, a biopharmaceutical company, and later as a candidate in the 2024 Republican Party presidential primaries. The son of Indian immigrants who settled in Ohio, Ramaswamy built a career in biotechnology and finance before pivoting to public commentary and political activism. His 2021 book Woke, Inc. brought him widespread attention as a critic of what he described as the politicization of corporate America. His presidential campaign, launched in February 2023, was marked by an energetic speaking style and policy positions that combined cultural conservatism with skepticism of established government institutions. After suspending his campaign in January 2024, he endorsed Donald Trump and was subsequently named, alongside Elon Musk, as co-head of the advisory body known as the Department of Government Efficiency (DOGE). Ramaswamy later withdrew from that role in January 2025 to pursue a campaign for Governor of Ohio.

---

Early Life

Vivek Ramaswamy was born on August 9, 1985, in Cincinnati, Ohio, to parents who had emigrated from the state of Kerala, India. His father, V.G. Ramaswamy, worked as an engineer, and his mother, Geetha Ramaswamy, is a geriatric psychiatrist. Growing up in a Hindu household in the Cincinnati suburb of Madeira, Ohio, Ramaswamy attended St. Xavier High School, a Jesuit institution, where he was an accomplished student and competitive tennis player, reaching a nationally ranked junior standing.

His upbringing, straddling the values of his Indian immigrant family and mainstream American culture, has been a recurring theme in his public writings and speeches. He has spoken about formative experiences navigating questions of identity and assimilation, which he later channeled into broader critiques of identity politics in his books and commentary.

---

Education

Ramaswamy enrolled at Harvard College, where he studied biology. He graduated in 2007 with a Bachelor of Arts degree, summa cum laude, and was elected to Phi Beta Kappa. While at Harvard, he also performed in a band called Optimus Ryme, playing guitar and singing, and has cited music as a lasting personal interest.

Following his undergraduate studies, Ramaswamy worked briefly in the finance industry before pursuing a law degree at Yale Law School, from which he graduated in 2013. It was during his time at Yale Law School that he began developing the ideas about corporate culture and American identity that would later define his public career. He has noted that attending Yale alongside future political and legal figures sharpened his thinking about institutional power.

---

Career

Finance

After graduating from Harvard, Ramaswamy joined QVT Financial, a New York City-based hedge fund, where he worked as an analyst focused on the biopharmaceutical sector. He remained at the firm on a part-time basis while attending Yale Law School, developing expertise in identifying undervalued drug compounds and navigating the complex licensing structures of the pharmaceutical industry. This period gave him practical knowledge of drug development economics that would prove foundational to his later entrepreneurial ventures.

Roivant Sciences

In 2014, Ramaswamy founded Roivant Sciences, a biopharmaceutical company headquartered in Basel, Switzerland, with significant operations in the United States. Roivant's business model centered on licensing drug candidates that had been shelved by larger pharmaceutical companies and developing them through subsidiary entities, called "Vants," each focused on a specific therapeutic area. These subsidiaries included Myovant Sciences, Axovant Sciences, and Dermavant Sciences, among others.

Axovant Sciences drew significant early attention when it went public in 2015 in what was, at the time, the largest biotechnology initial public offering in history, raising approximately $315 million. However, Axovant's lead Alzheimer's drug candidate, intepirdine, failed in a Phase 3 clinical trial in 2017, resulting in a sharp decline in the company's stock price. The episode drew scrutiny of Roivant's model and of Ramaswamy's leadership.

Despite that setback, Roivant continued to operate and expand. In 2019, the Japanese pharmaceutical company Sumitomo Dainippon Pharma made a significant investment in Roivant, acquiring a roughly 10 percent stake for approximately $3 billion, a transaction that validated the broader enterprise and substantially increased Ramaswamy's personal net worth. Roivant Sciences went public on the Nasdaq in 2021 through a merger with a special-purpose acquisition company.

Ramaswamy stepped back from his executive role at Roivant in 2021 to focus on writing and political commentary, though he retained a financial stake in the company.

Author and Public Commentator

In 2021, Ramaswamy published Woke, Inc.: Inside Corporate America's Social Justice Scam through Center Street, a conservative imprint of Hachette Book Group. The book argued that large corporations had adopted progressive political causes not out of genuine conviction but as a strategy to deflect regulatory scrutiny and court specific consumer demographics. The book became a New York Times bestseller and established Ramaswamy as a prominent critic of environmental, social, and governance (ESG) investing and what he termed "stakeholder capitalism."

He followed Woke, Inc. with a second book, Nation of Victims: Identity Politics, the Death of Merit, and the Path Back to Excellence (2022), which extended his cultural critique to what he described as a broader American tendency toward grievance-based politics. A third book, Truths, was published in 2023 in connection with his presidential campaign.

Ramaswamy became a frequent contributor to major opinion outlets and a recurring presence on television programs, including Fox News and various podcast platforms, building an audience among conservatives and libertarians critical of corporate and governmental institutions.

2024 Presidential Campaign

On February 21, 2023, Ramaswamy announced his candidacy for the Republican Party presidential nomination in a video posted online and in an interview on Tucker Carlson Tonight on Fox News. He positioned himself as an outsider candidate who would challenge both the administrative state and the cultural institutions he had critiqued in his books.

Ramaswamy qualified for and participated in multiple Republican primary debates, drawing attention for his confident and confrontational debating style. He consistently polled in third or fourth place in national surveys of Republican primary voters, trailing Donald Trump and, at various points, Ron DeSantis and Nikki Haley.

His campaign platform included pledges to dramatically reduce the size of the federal bureaucracy, abolish multiple federal agencies, end birthright citizenship for children of undocumented immigrants, and withdraw support from Ukraine in its conflict with Russia. He also advocated raising the federal voting age to 25, with an exception for those who had completed military service or passed a civics examination, a proposal that attracted both attention and criticism.

On January 15, 2024, following the Iowa caucuses in which he performed below expectations, Ramaswamy suspended his campaign and endorsed Donald Trump in remarks delivered at his campaign watch party in Des Moines, Iowa.

Department of Government Efficiency

Following Donald Trump's victory in the 2024 United States presidential election, Trump announced in November 2024 that Ramaswamy and Elon Musk would co-lead a new advisory body called the Department of Government Efficiency (DOGE), which despite its name was not a formal federal department but rather an external advisory council intended to recommend reductions in federal spending and regulation.

In January 2025, before the formal work of the body had concluded, Ramaswamy announced his withdrawal from DOGE, stating that he intended to run for Governor of Ohio in the 2026 election. The announcement came after he and Musk had reportedly had differences in approach and style.

---

Personal Life

Ramaswamy married Apoorva Ramaswamy (née Puranik), a physician specializing in laryngology, in 2015. The couple have two sons together. The family is based in Mariemont, Ohio, a suburb of Cincinnati. Ramaswamy identifies as Hindu and has cited his faith as an influence on his worldview, including his skepticism of what he describes as the quasi-religious nature of contemporary progressive activism.

An avid musician since his college years, Ramaswamy has performed guitar and vocals at various public events during his presidential campaign, including a notable appearance in which he performed Eminem's "Lose Yourself" at a campaign event, drawing media coverage. He has also spoken publicly about his interest in Nietzschean philosophy and the works of Alexis de Tocqueville as intellectual influences.

---

Recognition

Ramaswamy was included on Forbes' Midas List of top technology investors and was recognized by Fortune among influential figures in business. Woke, Inc. reached the New York Times Best Seller list in 2021. His presidential campaign attracted significant grassroots fundraising, with his campaign reporting strong small-donor contributions in early quarters of 2023. He received an honorary reception at the Conservative Political Action Conference (CPAC) in 2022 and 2023, where he spoke to large audiences and placed competitively in the organization's straw poll.

---

References

---

Categories

---